Abstract:
Background: Teratogenic exposure during pregnancy poses a significant risk to fetal
development, increasing the overall risk of major congenital malformations. Despite the serious
implications of teratogenic exposure due to the use of mood stabilizers, limited studies have been
conducted to assess the awareness of among women of reproductive age regarding these risks.
This study aims to assess the awareness of mood stabilizer teratogenic risks and the factors
affecting it in women of reproductive age with bipolar disorder attending follow-up treatment at
Jimma Medical Center, Ethiopia.
Objective: To assess awareness of mood stabilizer teratogenic risk and associated factors among
women of reproductive age with bipolar disorder attending follow-up treatment and counseling
practice of mental health practitioners at Jimma Medical Center, Southwest Ethiopia, 2025.
Methods: A mixed methods study with an embedded design was conducted from January to
March 2025. A total of 170 women were selected for the quantitative study using a consecutive
sampling technique. Data was collected through face-to-face interviews using structured and
semi structured questionnaire. The collected data using kobo tool box was exported to Statistical
Package for Social Science (SPSS) V.26.0 for analysis. Bivariate and multivariable logistic
regression analyses were performed to identify presence of associations. Adjusted odds ratios
(AOR) along with a 95% CI and P-value <0.05 were used to determine the strength of
association and to declare statistically significance in the final model. Purposive sampling
technique was used to select seven study participants for the qualitative approach. Transcripts
were imported to ATLAS and then data was coded and analyzed thematically. Interviews were
audio-recorded, transcribed verbatim, and translated from Amharic to English for analysis. A
thematic content analysis was conducted using ATLAS.ti, involving transcript coding, subtheme
grouping, theme refinement, and triangulation with observational data to ensure validity.
Results: Adequate awareness of teratogenic risks associated with mood stabilizers among
reproductive aged female patients with bipolar disorder attending follow-up treatment at
Psychiatry OPD of Jimma Medical Center was 28.8% (95% CI: 22.1-36.3). Factors associated
with adequate awareness were older age (AOR = 4.01, 95% CI: 1.12–14.5), higher education
levels (AOR = 10.7, 95% CI: 1.62–21.5), longer duration of illness (AOR = 7.98, 95% CI: 1.32
18.2), previous pregnancy while on medication (AOR = 4.56, 95% CI: 1.12–18.7), current
contraceptive use (AOR = 3.98, 95% CI: 1.06–14.9), pre-treatment pregnancy testing (AOR =
9.23, 95% CI: 2.70–31.6), counseling from healthcare professionals (AOR = 11.4, 95% CI: 1.39
23.1), and low perceived stigma (AOR = 3.64, 95% CI: 1.12–11.8). Qualitative insights revealed
that discussions about these risks and contraception are infrequent and often initiated by patients,
hindered by heavy workloads, limited resources, and cultural sensitivities among mental health
providers.
Conclusion: Approximately 71.2% of women with bipolar disorder at Jimma Medical Center
were not adequately aware of the teratogenic risks of mood stabilizers. Adequate awareness was
linked to older age, higher education, longer illness duration, prior pregnancy on mood stabilizer,
contraceptive use, pre-treatment pregnancy testing, professional guidance, and low stigma.
Qualitative findings show infrequent and reactive counseling, often patient-initiated or triggered
by positive pregnancy tests. Heavy workloads, limited resources, and lack of standardized
protocols hinder consistent risk discussions. Cultural sensitivities and assumptions of prior
counseling lead to inconsistent, biased counseling, leaving women uninformed. This lack of
communication leaves many women uninformed about their reproductive health, underscoring
the need for standardized protocols and culturally sensitive counseling to bridge the gap in
psychiatric care.